taguru,,2019-05-22 15:29:00,33.102,MDCO Medicines MDCO 3368 was the markets top quarterly gainer rising 41 tickeroncomeventid11411
sell1buy2,True,2019-05-22 12:17:00,32.66,MDCO since last Fridays close the shares are 13 Over the weekend ORION3 Inclisiran data was released and analysts were unanimously positive on it as a result Roth Capital analyst Yasmeen Rahimi believes the clean safety for Inclisiran over 3 years across a large cohort of patients should put the bearish safety overhang of siRNA drugs to rest and thus move MDCO at least by 20 higher The shorts are on the wrong side of this so they are manipulating it lower Meanwhile this story continues to get better This analyst think the data just released sb good enough to boost shares by 20 Not seeing any long sellers just the short mafia colluding to pain the tape and some HFT types going along with the intraday action Price action since Monday has diverged from the fundamental story
MRKEE,,2019-05-22 11:19:00,32.99,MDCO Out for now might look at reentry closer to 3250
zrumi,True,2019-05-22 10:35:00,32.978,MDCO what a pure garbage pos back to where it was on good news
shortvolumes,,2019-05-22 10:31:00,33.18,The short sale volume not short interest for MDCO on 20190521 is 44 shortvolumescomtMDCO via shortvolumes
